. Author manuscript; available in PMC: 2011 Mar 1.

Published in final edited form as: Respir Med. 2009 Oct 31;104(3):454–462. doi: 10.1016/j.rmed.2009.10.004

Table 2.

Characteristics of PAH Patients Included in Tissue Analysis

Variable	PAH Group
	n = 11
Female (%)	7 (63.6)
Age at Time of Tissue Acquisition	32.2 ± 13.0
Age at Diagnosis, yrs	26.5 ± 14.1
Mean PAP at Diagnosis, mm Hg	67.7 ± 17.1
Current Prostanoid Therapy, n (%)	11 (100)
Current Phosphodiesterase Inhibitor Therapy, n (%)	2 (0.2)
Current Endothelin Receptor Antagonist Therapy, n (%)	3 (0.3)

Values are mean ± S.D.